Preoperative chemotherapy in upfront resectable colorectal liver metastases: new elements for an old dilemma?

In early 2023, the European Society of Medical Oncology (ESMO) guidelines clarified the place of neoadjuvant chemotherapy (NAC) for resectable colorectal liver metastases (CRLM) [1].

Source: Cancer Treatment Reviews - February 6, 2024 Category: Cancer & Oncology Authors: Lorenzo Bernardi, Raffaello Roesel, Davit L. Aghayan, Pietro E. Majno-Hurst, Sara De Dosso, Alessandra Cristaudi Tags: Controversy Source Type: research